Han Chong Toh
- Oncology top 0.5%
- Immunology top 1%
- Molecular Biology top 5%
- Hepatology top 0.5%
- Cancer Research top 1%
- Co-authors
- Rong En TayValerie ChewPierce K. H. ChowJean‐Pierre AbastadoWhay Kuang ChiaKiat Hon LimAlexander Yaw Fui ChungAlessandra Nardin
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (30 papers)Immunotherapy and Immune Responses (24 papers)Cancer Immunotherapy and Biomarkers (21 papers)
- Cited by
- HepatologyOncologyImmunology
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Han Chong Toh
129 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.7k
- Immunology 2.1k
- Molecular Biology 1.8k
- Hepatology 1.3k
- Cancer Research 1.2k
Countries citing papers authored by Han Chong Toh
This map shows the geographic impact of Han Chong Toh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Chong Toh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Chong Toh more than expected).
Fields of papers citing papers by Han Chong Toh
This network shows the impact of papers produced by Han Chong Toh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Chong Toh. The network helps show where Han Chong Toh may publish in the future.
Co-authorship network of co-authors of Han Chong Toh
This figure shows the co-authorship network connecting the top 25 collaborators of Han Chong Toh. A scholar is included among the top collaborators of Han Chong Toh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Chong Toh. Han Chong Toh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 13 | |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 9 | |
| 10 | 2 | |
| 11 | 26 | |
| 12 | 18 | |
| 13 | 7 | |
| 14 | 12 | |
| 15 | 23 | |
| 16 | 32 | |
| 17 | 51 | |
| 18 | 55 | |
| 19 | 52 | |
| 20 | 54 |
About Han Chong Toh
Han Chong Toh is a scholar working on Hepatology, Oncology and Cancer Research, having authored 134 papers that have together received 6.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Immunotherapy and Immune Responses (24 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Hepatology (1.3k citations), Oncology (2.7k citations) and Immunology (2.1k citations). Han Chong Toh has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Rong En Tay, Valerie Chew, Pierce K. H. Chow, Jean‐Pierre Abastado, Whay Kuang Chia, Kiat Hon Lim, Alexander Yaw Fui Chung, Alessandra Nardin, Irene Oi‐Lin Ng and Mathias Heikenwälder. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.